Bryan J. Marascalchi, M.D. is an anesthesiologist, pain medicine physician, and businessman who has made significant contributions to the medical and technological fields. He is well-known for his work in entrepreneurship, advocacy, and advancing current knowledge in medicine. Dr. Marascalchi founded Pneumico, Inc., which provides breathing data, patient analytics, and alerts to providers – ventilation intelligence. He is also a co-founder of Patient Premier, Inc. a remote patient monitoring platform whose princcipal product Pain Scored collects and reports self-assessments and physiologic data to improve health. He is also an Assistant Professor of anesthesiology and pain medicine at the Vanderbilt University School of Medicine.
Education
Dr. Marascalchi received his Bachelor of Science degree in biology from the Renée Crown University Honors Program of Syracuse University and his Doctor of Medicine degree from the New York University School of Medicine. While studying at NYU, he pursued a research fellowship in bioinformatics and bio-design, with a specific focus on large database management and analysis, clinical trials, and healthcare product development. After completing medical school, he went on to complete an anesthesiology residency and pain medicine fellowship at the Johns Hopkins Hospital.
Medical career
Dr. Marascalchi specializes in treating patients with pain in the spine, complex regional pain syndrome, discogenic pain, postherpetic neuralgia, radicular pain including sciatica, and other neuropathic pain. He is experienced in performing neuromodulation procedures, and other invasive & non-invaisive procedures for the treatment of unrelenting pain. He also has expertise in clinical anesthesia, obstetric anesthesia, epidural placement, and spinal anesthesia. As of 2019, Marascalchi worked as an assistant professor of anesthesiology and pain medicine at the Johns Hopkins University School of Medicine. As of 2024, he worked as an assistant professor of anesthesiology and pain medicine at the Vanderbilt University School of Medicine.
His career in Anesthesiology and pain management has been inspired by his enthusiasm for entrepreneurship, advancing current knowledge, and improving the quality of life of patients and their families. He is well-published with over twenty manuscripts and abstracts accepted to academic journals, and has found entrepreneurial success with his extensive ability for healthcare device prototyping, inventing and patenting, software development, and web and mobile development. As a physician and patient advocate, he works with legislators, regulators, and industry partners to better understand the complex healthcare transformation that is occurring currently. He looks to the future, and aims to combine his experiences in healthcare technology, quality improvement, physician and patient advocacy, data analytics, and machine learning in order to advance our current knowledge within the field of medicine.
Entrepreneurship
Dr. Marascalchi has extensive experience in entrepreneurship, including healthcare device prototyping, inventing and patenting, software/web/mobile development, and machine learning. He founded Pneumico, Inc. and co-founded Patient Premier, Inc. His innovations have made a significant impact on the healthcare industry. Marascalchi’s involvement in both companies demonstrates his commitment to advancing current knowledge within the field of medicine and improving patient outcomes through technology. He has also been the recipient of Small Business Innovation Research awards from the National Science Foundation & grants from Amazon Web Services Health Equity Initiative.
Corporate
Dr. Marascalchi’s companies, Pneumico, Inc. and Patient Premier, Inc., have made significant contributions to healthcare.
Patient Premier
Patient Premier’s principal product Pain Scored is a remote patient monitoring platform that collects and reports self-assessments and physiologic data to improve health.
Pneumico
Pneumico’s product pipeline including the Ventel™ provides breathing data, patient analytics, and alerts to providers – ventilation intelligence. Ensuring guideline-specific parameters set by regulators are met.